A systematic review of epinephrine stability and sterility with storage in a syringe.
Adrenaline
Allergy
Anaphylaxis
Epinephrine
Prefilled
Stability
Sterility
Storage
Syringe
Time
Journal
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
ISSN: 1710-1484
Titre abrégé: Allergy Asthma Clin Immunol
Pays: England
ID NLM: 101244313
Informations de publication
Date de publication:
2019
2019
Historique:
received:
30
10
2018
accepted:
08
02
2019
entrez:
5
3
2019
pubmed:
5
3
2019
medline:
5
3
2019
Statut:
epublish
Résumé
Epinephrine is a lifesaving medication in the treatment of anaphylaxis. Epinephrine auto-injectors are the preferred method of epinephrine administration, but are not universally available or affordable. Little is known about the effects on epinephrine when it is drawn up in advance and stored as prefilled syringes. To study the stability and sterility of epinephrine when stored in syringes. We searched Embase, Medline, and Web of Science in June 2016 for all studies of epinephrine stored in syringes in concentrations between 0.1 and 1 mg/mL that measured epinephrine stability and/or sterility over time, regardless of date published or language. Three studies were included, one testing two concentrations of epinephrine. Only one study tested epinephrine 1 mg/mL, the concentration clinically relevant for intramuscular use during anaphylaxis. Neither this study nor the one study testing 0.7 mg/mL epinephrine found significant degradation after 56 and 90 days, respectively. One of the two studies testing epinephrine at a concentration of 0.1 mg/mL found significant degradation by 14 days; the other found no degradation up to 168 days. Two studies tested for bacterial growth, with none detected after 28 and 90 days, respectively. One study tested for fungal growth, with none detected after 90 days. Limited evidence suggests that syringes filled with 1 mg/mL epinephrine are stable and sterile for 90 days. More research is needed testing the duration of stability and sterility of prefilled syringes with the 1 mg/mL concentration most commonly used in anaphylaxis, testing more extensively in different storage conditions and across a wider range of marketed syringe brands.
Sections du résumé
BACKGROUND
BACKGROUND
Epinephrine is a lifesaving medication in the treatment of anaphylaxis. Epinephrine auto-injectors are the preferred method of epinephrine administration, but are not universally available or affordable. Little is known about the effects on epinephrine when it is drawn up in advance and stored as prefilled syringes.
OBJECTIVE
OBJECTIVE
To study the stability and sterility of epinephrine when stored in syringes.
METHODS
METHODS
We searched Embase, Medline, and Web of Science in June 2016 for all studies of epinephrine stored in syringes in concentrations between 0.1 and 1 mg/mL that measured epinephrine stability and/or sterility over time, regardless of date published or language.
RESULTS
RESULTS
Three studies were included, one testing two concentrations of epinephrine. Only one study tested epinephrine 1 mg/mL, the concentration clinically relevant for intramuscular use during anaphylaxis. Neither this study nor the one study testing 0.7 mg/mL epinephrine found significant degradation after 56 and 90 days, respectively. One of the two studies testing epinephrine at a concentration of 0.1 mg/mL found significant degradation by 14 days; the other found no degradation up to 168 days. Two studies tested for bacterial growth, with none detected after 28 and 90 days, respectively. One study tested for fungal growth, with none detected after 90 days.
CONCLUSIONS
CONCLUSIONS
Limited evidence suggests that syringes filled with 1 mg/mL epinephrine are stable and sterile for 90 days. More research is needed testing the duration of stability and sterility of prefilled syringes with the 1 mg/mL concentration most commonly used in anaphylaxis, testing more extensively in different storage conditions and across a wider range of marketed syringe brands.
Identifiants
pubmed: 30828350
doi: 10.1186/s13223-019-0324-7
pii: 324
pmc: PMC6383228
doi:
Types de publication
Journal Article
Langues
eng
Pagination
7Références
J Allergy Clin Immunol. 2000 May;105(5):1025-30
pubmed: 10808186
Arch Pediatr. 2000 Dec;7(12):1347-52
pubmed: 11147073
Prehosp Disaster Med. 2001 Jan-Mar;16(1):14-7
pubmed: 11367931
J Allergy Clin Immunol. 2001 Dec;108(6):1040-4
pubmed: 11742286
Pediatr Crit Care Med. 2001 Oct;2(4):315-7
pubmed: 12793933
Int J Obstet Anesth. 2002 Oct;11(4):252-4
pubmed: 15321530
N Z Med J. 2006 May 05;119(1233):U1965
pubmed: 16680178
Pediatrics. 2007 Mar;119(3):638-46
pubmed: 17332221
Ann Allergy Asthma Immunol. 2009 May;102(5):403-9
pubmed: 19492662
Ann Allergy Asthma Immunol. 2009 Jun;102(6):500-3
pubmed: 19558009
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
Asian Pac J Allergy Immunol. 2010 Mar;28(1):53-7
pubmed: 20527517
J Allergy Clin Immunol. 2010 Dec;126(6):1105-18
pubmed: 21134568
Patient Prefer Adherence. 2011 Mar 28;5:173-80
pubmed: 21573048
Pediatrics. 2011 Jul;128(1):e9-17
pubmed: 21690110
Postgrad Med. 1975 Jun;57(7):139-40
pubmed: 236552
Am J Health Syst Pharm. 2014 Jan 15;71(2):145-66
pubmed: 24375608
Am J Med. 2014 Jan;127(1 Suppl):S34-44
pubmed: 24384136
Ann Allergy Asthma Immunol. 2014 Dec;113(6):599-608
pubmed: 25466802
Ann Emerg Med. 2015 Aug;66(2):97-106.e3
pubmed: 25701295
Ann Allergy Asthma Immunol. 2015 Apr;114(4):354-356.e1
pubmed: 25707326
Curr Opin Allergy Clin Immunol. 2015 Aug;15(4):323-8
pubmed: 26110682
Allergy Asthma Clin Immunol. 2015 Jun 12;11(1):20
pubmed: 26131015
Ann Allergy Asthma Immunol. 2016 Jul;117(1):79-87
pubmed: 27221065
Ann Intern Med. 2017 Jun 20;166(12):918-919
pubmed: 28492859
Ugeskr Laeger. 1996 Aug 5;158(32):4539-43
pubmed: 8759396